Substance Name: Leronlimab [USAN]
RN: 674782-26-4
UNII: Y1J4NP8FF0
Notes
- A humanised form of the PA14 antibody against the HIV coreceptor CCR5.
- A humanised form of the PA14 antibody against the HIV coreceptor CCR5.
AIDSINFO: PRO-140 belongs to a class (group) of HIV drugs called entry and fusion inhibitors.2 Entry and fusion inhibitors block HIV from getting into and infecting certain cells of the immune system. This prevents HIV from multiplying and can reduce the amount of HIV in the body. - AIDSINFO: PRO-140 belongs to a class (group) of HIV drugs called entry and fusion inhibitors.2 Entry and fusion inhibitors block HIV from getting into and infecting certain cells of the immune system. This prevents HIV from multiplying and can reduce the amount of HIV in the body.
Molecular Formula
- Unspecified
Classification Codes
- Anti-HIV Agents
- Anti-Infective Agents
- Anti-Retroviral Agents
- Antiviral (COVID-19)
- Antiviral Agents
- HIV Fusion Inhibitors
- Treatment of HIV Infection
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Names and Synonyms
Name of Substance
- Leronlimab [USAN]
- PRO-140 monoclonal antibody
Synonyms
- Leronlimab
- PA14
- PRO 140
- UNII-Y1J4NP8FF0
- WHO 10751
Systematic Name
- PRO-140
Registry Numbers
CAS Registry Number
- 674782-26-4
FDA UNII
- Y1J4NP8FF0
System Generated Number
- 0674782264